Association between the level of high sensitivity C-reactive protein and risk of breast cancer among non-diabetic females; A prospective study in Kailuan group

Chinese Journal of Oncology

Volumn 36, Issue 12, 2014, Pages 944-948

  Wang, Gang ^a   Li, Ni ^a   Cao, Liying ^a   Chen, Shuohua ^a   Guo, Lanwei ^a   Su, Kai ^a   Li, Fang ^a   Cui, Hong ^a   He, Jie ^a   Dai, Min ^a   Zou, Yuhuan ^a   Sun, Dongsheng ^a   Wu, Shouling ^a  

^a Kailuan Hospital   (China)

Author keywords

Breast neoplasms; Cohort studies; Epidemiology; Females; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; SMOKING; BREAST NEOPLASMS; DIABETES MELLITUS; INCIDENCE; METABOLISM; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; RISK FACTOR;

BODY MASS INDEX; BREAST NEOPLASMS; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SMOKING;

EID: 84930902870     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/ema.i.issn.0253-3766.2014.12.015     Document Type: Article

References (23)

1. Youlden DR, Cramb SM, Yip CH, et al. Incidence and mortality of female breast cancer in the Asia-Pacific region[J]. Cancer Biol Med, 2014, 11(2):101-115.
2. Touvier M, Fezeu L, Ahluwalia N, et al. Association between prediagnostic biomarkers of inflammation and endothelial function anil cancer risk; a nested case-control study [J]. Am J Epidemiol, 2013, 177(1):3-13.
3. Toriola AT, Surcel HM, Lundin E, et al. Insulin-like growth faclor-I and C-reactive protein during pregnancy and maternal risk of nonepithelial ovarian cancer: a nested case-control study[J]. Cancer Causes Control, 2011, 22(11):1607-1611.
4. Ollberding NJ, Kim Y, Shvetsov YB, et al. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer [J]. Cancer Prev Res (Phila), 2013, 6(3):188-195.
5. De Bruijn KM, Arends LR, Hansen BE, et al. Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal eancer[J]. Br J Surg, 2013, 100(11):1421-1429.
6. Pradeep AR, Martande SS, Singh SP, et al. Correlation of human S100A12 (EN-RAGE) and high-sensitivity C-reactive protein as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes[J]. Inflamm Res, 2014, 63(4):317-323.
7. Wu S, Huang Z, Yang X, et al. Cardiovascular events in a prehypertensive Chinese population; four-year follow-up study [J]. Int J Cardiol, 2013, 167(5):2196-2199.
8. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer[J]. J Clin Oncol, 2009, 27(13):2217-2224.
9. Coussens LM, Werb Z. Inflammation and cancer [J]. Nature, 2002, 420(6917):860-867.
10. Yigit E, Gönüllü G, Yücel I, et al. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer[J]. Eur J Intern Med, 2008, 19(8):602-607.
11. Guo YZ, Pan L, Du CJ, et al. Association between C-reaclive protein and risk of cancer; a meta-analysis of prospective cohort studies[J]. Asian Pac J Cancer Prev, 2013, 14(1):243-248.
12. Gaudel MM, Patel AV, Teras LR, et al. Obesity-related markers and breast cancer in CPS-1I Nutrition Cohort [J]. Int J Mol Epidemiol Genet, 2013, 4(3):156-166.
13. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk; the Rotterdam Study[J]. J Clin Oncol, 2006, 24(33):5216-5222.
14. Prizment AE, Folsom AR, Dreyfus J, et al. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the atherosclerosis risk in communities study [J]. Cancer Causes Control, 2013, 24(12):2077-2087.
15. Zhang SM, Lin J, Cook NR, et al. C-reactive protein and risk of breast cancer[J]. J Natl Cancer Inst, 2007, 99(11):890-894.
16. Heikkil K, Harris R, Lowe G, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk; findings from two prospective cohorts and a rncla-analysis [J]. Cancer Causes Control, 2009, 20(1):15-26.
17. Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort [J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(10):2413-2418.
18. Mahmoud FA, Rivera NT. The role of C-reactive protein as a prognostic indicator in advanced cancer [J]. Curr Oncol Rep, 2002, 4(3):250-255.
19. Paseeri V, Cammamta G. C-reactive pnotein and risk of colon cancer [J]. JAMA, 2004, 291(23):2818-2819.
20. Hussain SP, Harris CC. Inflammation and cancer an ancient link with novel potentials [J]. Int J Cancer, 2007, 121(11):2373-2380.
21. Aggarwal BB, Shishodia S, Sandur SK, et al. Inflammation and cancer: how hot is the link? [J]. Biochem Pharmacol, 2006, 72(11):1605-1621.
22. Pierce BL, Ballard-Barbash R, Bernstein L, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 2009, 27(21):3437-3444.
23. Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs; prospective results from the women's health initiative[J]. Cancer Res, 2003, 63(18):6096-6101.